Scholars Central

Conference abstractPublished 21 Oct 2013

Strategic management of global post approval regulatory activities

Authors: Linda Yang

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Biopharmaceutical companies have continued to expand their frontiers to attain a global reach, with presence in many regions and countries, and therefore exposed to many regulatory requirements and operating standards. The challenges of globalization in a heterogeneous world with an evolving regulatory landscape and expectations of multiple stakeholders have increased the complexity, unpredictability and intensity of the biopharmaceutical product development and registration process. Activities traditionally focused on the post-approval period of the product life cycle, such as CMC changes and safety reporting, demanding a high degree of specialized knowledge for appropriate compliance from countries to countries. Thus, require companies to develop strategic approaches to manage the post-marketing activities and lifecycle optimization.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalPharmaceutical Regulatory Affairs: Open Access
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Linda Yang”